- Q3 revenue fell 30% YoY to $32.9M, with Billings down 32% to $57.2M and Adjusted EBITDA down 88% to $0.4M.
- Net loss stood at $(8.9)M compared to $(72.7)M in Q3 2025; diluted loss per share from continuing operations was $(1.26).
- Q4 2026 revenue guidance guided down 23% to 31% YoY ($35.0M - $39.0M) with Adj. EBITDA between $(1.0)M and $2.0M.
Why is $CDLX moving today? · SEC 8-K archive
$CDLX SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $CDLX: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $CDLX filing catalyst
Why did $CDLX trigger an AI stock catalyst alert?
$CDLX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -6.5/10). Headline: Cardlytics Q3 Revenue Drops 30% YoY, Q4 Guidance Projects Continued Double-Digit Decline. Key points: - Q3 revenue fell 30% YoY to $32.9M, with Billings down 32% to $57.2M and Adjusted EBITDA down 88% to $0.4M. - Net loss stood at $(8.9)M compared to $(72.7)M in Q3 2025; diluted loss per share from continuing operations was $(1.26). - Q4 2026 revenue guidance guided down 23% to 31% YoY ($35.0M - $39.0M) with Adj. EBITDA between $(1.0)M and $2.0M.
How did $CDLX stock react after the SEC filing?
After the SEC 8-K for $CDLX, observed market reaction: T0 price $2.19. Past moves do not guarantee future results.
Where can I get real-time $CDLX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CDLX via Telegram and the VIP Web Terminal from €10/month.